HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.

Abstract
Transforming growth factor-β (TGF-β) is an important inducer of the epithelial-to-mesenchymal transition (EMT) in various cancers. Our previous study demonstrated that prohaptoglobin (proHp) stimulates Smad1/5 activation via ALK1, a TGF-β type I receptor, in endothelial cells, suggesting that proHp plays a role in TGF-β signaling. However, the function of proHp in cellular events downstream of Smads remains unclear. The current study investigated the effects of proHp on TGF-β-mediated Smad-dependent EMT induction and cell invasion in vitro using proHp-overexpressing SK-Hep1 liver cancer cells. The results of Western blotting, quantitative real-time RT-PCR, and immunocytochemistry indicated that proHp downregulated expression of mesenchymal marker and EMT regulator such as N-cadherin, vimentin, and twist, and upregulated expression of the epithelial marker E-cadherin. Compared with control cells, proHp-overexpressing cells exhibited high levels of ALK1/2/3 receptors and markedly increased Smad1/5 phosphorylation. Interestingly, proHp attenuated TGF-β-induced expression of mesenchymal markers and Smad2/3 phosphorylation. It also significantly suppressed cell invasion and migration. Knockdown of Smad1/5 abolished the inhibitory effects of proHp on TGF-β-stimulated Smad2/3 phosphorylation and mesenchymal marker expression. These findings indicate that proHp suppresses the TGF-β-induced EMT and cell invasion in vitro by enhancing Smad1/5 activation via ALK1/2/3 receptors and thus suppressing the Smad2/3 signaling pathway in SK-Hep1 cells. This study suggests that proHp may prevent a de-differentiation of hepatic cells and induce a cell differentiation by regulating the Smad signaling pathway.
AuthorsMi-Kyung Oh, Hansol Joo, In-Sook Kim
JournalPloS one (PLoS One) Vol. 17 Issue 5 Pg. e0266409 ( 2022) ISSN: 1932-6203 [Electronic] United States
PMID35580109 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Haptoglobins
  • Protein Precursors
  • SMAD1 protein, human
  • SMAD2 protein, human
  • SMAD3 protein, human
  • SMAD5 protein, human
  • Smad Proteins
  • Smad1 Protein
  • Smad3 Protein
  • Smad5 Protein
  • Transforming Growth Factor beta
  • prohaptoglobin
Topics
  • Cell Line, Tumor
  • Cell Movement
  • Endothelial Cells (metabolism)
  • Epithelial-Mesenchymal Transition
  • Haptoglobins (metabolism)
  • Humans
  • Liver Neoplasms (genetics, metabolism, pathology)
  • Protein Precursors (metabolism)
  • Signal Transduction
  • Smad Proteins (metabolism)
  • Smad1 Protein (metabolism)
  • Smad3 Protein (metabolism)
  • Smad5 Protein (metabolism)
  • Transforming Growth Factor beta (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: